AG
ACET icon

Algert Global’s Adicet Bio ACET Stock Holding History

Algert Global’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-824
Closed -$118K – 1120
2022
Q4 		$118K Sell
824
-1,188
-59% -$296K 0.01% 1057
2022
Q3 		$458K Buy
2,012
+974
+94% +$247K 0.03% 827
2022
Q2 		$243K Buy
+1,038
New +$228K 0.02% 970
2020
Q3 		– Sell
-153
Closed -$37K – 394
2020
Q2 		$37K Sell
153
-321
-68% -$63.1K 0.01% 401
2020
Q1 		$55K Buy
+474
New +$70.4K 0.02% 380

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Algert Global's ACET Position: Q1 2023 in Review

Algert Global sold out of Adicet Bio (ACET) in Q1 2023, closing a stake of 824 shares — an estimated $118K sold.

Algert Global first reported a position in ACET in Q1 2020 and held it in 5 quarters. The position peaked at $458K in Q3 2022. 107 funds tracked by Wall St. Rank hold ACET as of Q1 2023.

  • Algert Global reported no remaining Adicet Bio position as of Q1 2023 after selling out during the quarter.
  • Algert Global sold 824 Adicet Bio shares in Q1 2023, an estimated $118K.
  • Algert Global first reported a position in Adicet Bio in Q1 2020 and held it in 5 quarters.
  • Algert Global's Adicet Bio position peaked at $458K in Q3 2022.
  • 107 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2023.

Based on Algert Global's 13F filing for Q1 2023, filed 12 May 2023.